NFE2L2 and hepatocellular carcinoma: Apigenin acts as a potential chemosensitizer for hepatocellular carcinoma by enabling the sensitization of doxorubicin-treated BEL-7402 cells through the miR101/NRF2-related apoptotic pathway [79].